IQ EQ FUND MANAGEMENT (IRELAND) Ltd

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1620943 DUBLIN 2, L2

Position in RXRX

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$9,557,843

+$1,706,616 QoQ

Shares Held

2,604,317

+1.8% QoQ

Ownership

0.486%

of shares outstanding

% of Portfolio

0.62%

of 13F equity value

Holder Rank

#25

of 344 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

IQ EQ FUND MANAGEMENT (IRELAND) Ltd holds $92,297,435 across 13 Biotechnology names. RXRX ranks #5 (10.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CRSP	CRISPR Therapeutics AG	381,991	$20,833,789
2	TWST	Twist Bioscience Corp	191,845	$19,737,013
3	BEAM	Beam Therapeutics Inc.	455,954	$15,648,341
4	NTLA	Intellia Therapeutics, Inc.	777,948	$13,162,880
5	RXRX	Recursion Pharmaceuticals, Inc. This page	2,604,317	$9,557,843
6	ABSI	Absci Corp	478,520	$5,546,046
7	NRIX	Nurix Therapeutics, Inc.	89,885	$2,180,610
8	ATAI	AtaiBeckley Inc.	252,913	$1,332,851

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$9,557,843	2,604,317	+1.8%	Shares	Sole	2026-07-31
2026-03-31	$7,851,227	2,557,403	+6.4%	Shares	Sole	2026-05-11
2025-12-31	$9,832,842	2,404,118	+35.4%	Shares	Sole	2026-02-12
2025-09-30	$8,661,975	1,774,995	+94.8%	Shares	Sole	2025-11-05
2025-06-30	$4,610,090	911,085	+135.3%	Shares	Sole	2025-08-01
2025-03-31	$2,048,483	387,237	+93.2%	Shares	Sole	2025-05-09
2024-12-31	$1,355,177	200,470	+143.4%	Shares	Sole	2025-02-12
2024-09-30	$542,699	82,352	+104.6%	Shares	Sole	2024-10-16
2024-06-30	$301,882	40,251	—	Shares	Sole	2024-07-29
No filing history on record for this holder in this stock.